Tao Wang Yan Huang Xing Huang Zheng Lv Shuo Tian Xin Ma Xu Zhang
10.3389/fonc.2021.735077
Front Oncol
2021 Oct 15;11:735077.
complete response (cr) follow-up hereditary leiomyomatosis and renal cell cancer (hlrcc) immunotherapy mutation
CC BY
https://pubmed.ncbi.nlm.nih.gov/34722283/
Case Reports
PMC8554149
34722283
Complete Response of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)-Associated Renal Cell Carcinoma to Pembrolizumab Immunotherapy: A Case Report
2021